File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1007/s00520-019-04722-3
- Scopus: eid_2-s2.0-85064215228
- PMID: 30919153
- WOS: WOS:000469516100005
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Prophylactic and therapeutic effects of honey on radiochemotherapy-induced mucositis: a meta-analysis of randomized controlled trials
Title | Prophylactic and therapeutic effects of honey on radiochemotherapy-induced mucositis: a meta-analysis of randomized controlled trials |
---|---|
Authors | |
Keywords | Chemotherapy Honey Meta-analysis Mucositis Radiotherapy |
Issue Date | 2019 |
Publisher | Springer Verlag. The Journal's web site is located at http://link.springer.de/link/service/journals/00520/index.htm |
Citation | Supportive Care in Cancer, 2019, v. 27 n. 7, p. 2361-2370 How to Cite? |
Abstract | Purpose: Oral mucositis is a common side effect of radiochemotherapy and may adversely affect the patients’ quality of life (QoL). Honey application may reduce the mucositis grade in patients. Here, we conducted a meta-analysis of randomized controlled trials (RCTs) to evaluate the prophylactic and therapeutic effects of honey on radiochemotherapy-induced oral mucositis. Methods: Publications on RCTs were extracted from the PubMed, Embase, CINAHL, and Cochrane Library databases. The primary outcomes were mucositis grades and pain scores. Secondary outcomes were the recovery time and QoL. The study was registered with PROSPERO (number CRD42018108486). Results: Nineteen RCTs, involving 1276 patients, were reviewed. Honey considerably mitigated oral mucositis in both prophylactic and therapeutic phases. In the prophylactic phase, intolerable mucositis development was significantly prevented in the honey-treated group (RR = 0.18, 95% confidence interval [CI] = 0.09 to 0.41). Patients treated with honey showed significant decrease in pain scores in the first month of treatment (weighted mean difference [WMD] = − 3.25, 95% CI = − 4.41 to − 2.09) and at the end of the treatment (WMD = − 2.32, 95% CI = − 4.47 to − 0.18). Conclusion: Honey, which is relatively cheap and easily available, prevented mucositis and effectively mitigate mucositis in patients after radiochemotherapy. Moreover, it significantly reduced the mucositis grade and engendered a fast and painless healing process. Therefore, honey use during and after radiochemotherapy is recommended for mucositis prevention and treatment. © 2019, Springer-Verlag GmbH Germany, part of Springer Nature. |
Persistent Identifier | http://hdl.handle.net/10722/275349 |
ISSN | 2023 Impact Factor: 2.8 2023 SCImago Journal Rankings: 1.007 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Liu, TM | - |
dc.contributor.author | Luo, YW | - |
dc.contributor.author | Tam, KW | - |
dc.contributor.author | Lin, C | - |
dc.contributor.author | Huang, TW | - |
dc.date.accessioned | 2019-09-10T02:40:46Z | - |
dc.date.available | 2019-09-10T02:40:46Z | - |
dc.date.issued | 2019 | - |
dc.identifier.citation | Supportive Care in Cancer, 2019, v. 27 n. 7, p. 2361-2370 | - |
dc.identifier.issn | 0941-4355 | - |
dc.identifier.uri | http://hdl.handle.net/10722/275349 | - |
dc.description.abstract | Purpose: Oral mucositis is a common side effect of radiochemotherapy and may adversely affect the patients’ quality of life (QoL). Honey application may reduce the mucositis grade in patients. Here, we conducted a meta-analysis of randomized controlled trials (RCTs) to evaluate the prophylactic and therapeutic effects of honey on radiochemotherapy-induced oral mucositis. Methods: Publications on RCTs were extracted from the PubMed, Embase, CINAHL, and Cochrane Library databases. The primary outcomes were mucositis grades and pain scores. Secondary outcomes were the recovery time and QoL. The study was registered with PROSPERO (number CRD42018108486). Results: Nineteen RCTs, involving 1276 patients, were reviewed. Honey considerably mitigated oral mucositis in both prophylactic and therapeutic phases. In the prophylactic phase, intolerable mucositis development was significantly prevented in the honey-treated group (RR = 0.18, 95% confidence interval [CI] = 0.09 to 0.41). Patients treated with honey showed significant decrease in pain scores in the first month of treatment (weighted mean difference [WMD] = − 3.25, 95% CI = − 4.41 to − 2.09) and at the end of the treatment (WMD = − 2.32, 95% CI = − 4.47 to − 0.18). Conclusion: Honey, which is relatively cheap and easily available, prevented mucositis and effectively mitigate mucositis in patients after radiochemotherapy. Moreover, it significantly reduced the mucositis grade and engendered a fast and painless healing process. Therefore, honey use during and after radiochemotherapy is recommended for mucositis prevention and treatment. © 2019, Springer-Verlag GmbH Germany, part of Springer Nature. | - |
dc.language | eng | - |
dc.publisher | Springer Verlag. The Journal's web site is located at http://link.springer.de/link/service/journals/00520/index.htm | - |
dc.relation.ispartof | Supportive Care in Cancer | - |
dc.rights | This is a post-peer-review, pre-copyedit version of an article published in [insert journal title]. The final authenticated version is available online at: http://dx.doi.org/[insert DOI] | - |
dc.subject | Chemotherapy | - |
dc.subject | Honey | - |
dc.subject | Meta-analysis | - |
dc.subject | Mucositis | - |
dc.subject | Radiotherapy | - |
dc.title | Prophylactic and therapeutic effects of honey on radiochemotherapy-induced mucositis: a meta-analysis of randomized controlled trials | - |
dc.type | Article | - |
dc.identifier.email | Lin, C: lincc@hku.hk | - |
dc.identifier.authority | Lin, C=rp02265 | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1007/s00520-019-04722-3 | - |
dc.identifier.pmid | 30919153 | - |
dc.identifier.scopus | eid_2-s2.0-85064215228 | - |
dc.identifier.hkuros | 304285 | - |
dc.identifier.volume | 27 | - |
dc.identifier.issue | 7 | - |
dc.identifier.spage | 2361 | - |
dc.identifier.epage | 2370 | - |
dc.identifier.isi | WOS:000469516100005 | - |
dc.publisher.place | Germany | - |
dc.identifier.issnl | 0941-4355 | - |